Morphogen-IX
Morphogen-IX is a drug discovery company that develops bone morphogenetic proteins for the treatment of pulmonary arterial hypertension.
Business Model:
Revenue: $1M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Morphogen-IX Information
Geographic Data
Address: Babraham Research Campus
City: Cambridge
State: england
Zip: CB22 3AT
Country: GB
Financial Info
Stage:
series b
Raised Last:
$23M
Raised Total:$23M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Morphogen-IX is a drug discovery company that develops bone morphogenetic proteins for the treatment of pulmonary arterial hypertension.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2018 | Series B | 3 | $23.3M |
Cambridge Innovation Capital Medicxi University of Cambridge Enterprise Cambridge Innovation Capital Medicxi University of Cambridge Enterprise |
1/2016 | Series A | 3 | $2.1M |
Cambridge Innovation Capital Index Ventures University of Cambridge Enterprise Cambridge Innovation Capital Index Ventures University of Cambridge Enterprise |
12/2018 | Series B | $23.2M |
Medicxi Cambridge Innovation Capital Cambridge Enterprise |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
